Intracranial Rosai-Dorfman disease
Related Experiment Video
Updated: Jan 26, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Bo Yuan Huang1, Miao Zong1, Wen Jing Zong2
1Department of Neurosurgery, Beijing Electric Power Hospital, Capital Medical University, Beijing, China.
Abstract:
Rosai-Dorfman disease (RDD) is a rare histioproliferative disorder that only occasionally involves the central nervous system. We present the diagnosis and treatment of five patients with intracranial RDD. The patients were preoperatively misdiagnosed as meningioma or eosinophilic granuloma. All five patients were treated by total or subtotal surgical resection and none of them experienced recurrence. Histopathological examination showed a characteristic emperipolesis, the lymphocytes were engulfed in the S-100 protein and CD68 positive histiocytes, with negative expression of CD1a. Preoperative diagnosis of intracranial RDD is still challenging because the lesion is usually a dural-based lesion that mimics a meningioma. Surgical resection is an effective treatment and radiotherapy, steroid and chemotherapy has not demonstrated reliable therapeutic efficiency.
Insights
Rosai-Dorfman disease (RDD) is a rare brain disorder. Surgical resection is an effective treatment for intracranial RDD, with no recurrences observed in this study.
Area of Science:
- Neurology
- Histopathology
- Oncology
Background:
- Rosai-Dorfman disease (RDD) is a rare histioproliferative disorder.
- Central nervous system involvement is infrequent.
- Intracranial RDD often mimics other dural-based lesions like meningioma.
Observation:
- Five patients with intracranial RDD were diagnosed and treated.
- Preoperative misdiagnosis was common, with patients initially suspected of having meningioma or eosinophilic granuloma.
- Histopathology revealed characteristic emperipolesis with S-100 and CD68 positive histiocytes, and negative CD1a expression.
Findings:
- Surgical resection (total or subtotal) was performed on all five patients.
- No recurrence was observed in any patient post-surgery.
- Preoperative diagnosis remains challenging due to the lesion's dural-based nature.
Implications:
- Surgical resection is a highly effective treatment for intracranial RDD.
- Radiotherapy, steroids, and chemotherapy have shown limited therapeutic efficacy.
- Early and accurate diagnosis is crucial for effective management of intracranial RDD.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Principles of Disease Surveillance
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

